Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 10/20 | 0.52 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.52 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8910838 | 0.79 | FDPS (0.43) | FDPSGGPS1SMPD1CES2 | |
| SCHEMBL16360116 | 0.79 | FDPS (0.43) | FDPSGGPS1SMPD1CES2 | |
| SCHEMBL2780873 | 0.79 | FDPS (0.54) | FDPSGGPS1SMPD1CES2LPAR1 | |
| SCHEMBL11572196 | 0.72 | FDPS (0.50) | FDPSGGPS1SMPD1CES2 | |
| SCHEMBL2188894 | 0.72 | FDPS (0.50) | FDPSGGPS1SMPD1 | |
| SCHEMBL24761603 | 0.72 | FDPS (0.50) | FDPSGGPS1SMPD1CES2 | |
| SCHEMBL2051180 | 0.72 | FDPS (0.50) | FDPSGGPS1SMPD1 | |
| SCHEMBL2346921 | 0.72 | FDPS (0.50) | FDPSGGPS1SMPD1CES2 | |
| SCHEMBL308388 | 0.72 | FDPS (0.50) | FDPSGGPS1SMPD1 | |
| SCHEMBL9374930 | 0.72 | FDPS (0.50) | FDPSGGPS1SMPD1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6506393-B2 | Administering phosphocholine compound; leishmaniasis treatment | ZENTARIS AG (DE) | 2003-01-14 | — | — | US | disclosed |
| US-6254879-B1 | QUATERNARIUMAMINOETHYLPHOSPHATES | Max-Planck-Gessellschaft zun Förderung der Wissenschaften e.V. (DE) | 2001-07-03 | — | — | US | disclosed |